Document is current
Any future updates will be listed below
-
Authors
Miller, Eden
Chuang, Joyce S.
Roberts, Gregory J.
Nabutovsky, Yelena
Virdi, Naunihal https://orcid.org/0000-0002-8833-1490
Wright, Eugene E. Jr.
-
Funding
Funding for this research was provided by:
Abbott Diabetes Care
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 28 June 2024
First Online: 15 July 2024
Declarations
:
: Eden Miller received consulting fees from Abbott, Astra Zeneca, Novo Nordisk, Boehringer Ingelheim, Eli Lilly, Merck, Sanofi US, and acted as a speaker for Abbott, Boehringer Ingelheim, Eli Lilly, and Novo Nordisk. Eugene E. Wright received consulting fees from Abbott, Bayer, Boehringer Ingelheim, Eli Lilly, Sanofi US, and acted as a speaker for Abbott, Bayer, Boehringer Ingelheim and Eli Lilly. Joyce S. Chuang, Gregory J. Roberts, Yelena Nabutovsky, and Naunihal Virdi are employees and stockholders of Abbott.
: Ethics committee approval was not required as the data available for analysis were de-identified and not traceable back to an individual. Optum’s de-identified Market Clarity Data was used with permission under the data use agreement between Abbott and Optum.
